1. Academic Validation
  2. Tankyrase-mediated ADP-ribosylation is a regulator of TNF-induced death

Tankyrase-mediated ADP-ribosylation is a regulator of TNF-induced death

  • Sci Adv. 2022 May 13;8(19):eabh2332. doi: 10.1126/sciadv.abh2332.
Lin Liu 1 2 Jarrod J Sandow 1 2 Deena M Leslie Pedrioli 3 Andre L Samson 1 2 Natasha Silke 1 Tobias Kratina 1 Rebecca L Ambrose 4 5 Marcel Doerflinger 1 2 Zhaoqing Hu 1 Emma Morrish 1 2 Diep Chau 1 Andrew J Kueh 1 2 Cheree Fitzibbon 1 2 Marc Pellegrini 1 2 Jaclyn S Pearson 4 5 6 Michael O Hottiger 3 Andrew I Webb 1 2 Najoua Lalaoui 1 2 John Silke 1 2
Affiliations

Affiliations

  • 1 The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
  • 2 Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia.
  • 3 Department of Molecular Mechanisms of Disease (DMMD), University of Zurich, 8057 Zürich, Switzerland.
  • 4 Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.
  • 5 Department of Molecular and Translational Research, Monash University, Clayton, VIC, Australia.
  • 6 Department of Microbiology, Monash University, Clayton, VIC, Australia.
Abstract

Tumor necrosis factor (TNF) is a key component of the innate immune response. Upon binding to its receptor, TNFR1, it promotes production of Other cytokines via a membrane-bound complex 1 or induces cell death via a cytosolic complex 2. To understand how TNF-induced cell death is regulated, we performed mass spectrometry of complex 2 and identified tankyrase-1 as a native component that, upon a death stimulus, mediates complex 2 poly-ADP-ribosylation (PARylation). PARylation promotes recruitment of the E3 Ligase RNF146, resulting in proteasomal degradation of complex 2, thereby limiting cell death. Expression of the ADP-ribose-binding/hydrolyzing severe acute respiratory syndrome coronavirus 2 macrodomain sensitizes cells to TNF-induced death via abolishing complex 2 PARylation. This suggests that disruption of ADP-ribosylation during an Infection can prime a cell to retaliate with an inflammatory cell death.

Figures